The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Carbamazepine
Carbamazepine · CARBAMAZEPINE 300 mg/1 · Capsule, Extended Release · Oral · Bryant Ranch Prepack
NDC 72162-1715-02 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 30698-0423-12) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$4.73per unit
middle half $4.68–$4.81 · 69 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $4.73
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
1%of plans cover it
tier 4 · prior auth 0% · step therapy 22% · qty limit 22%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for carbamazepine (oral solid) in the next 90 days
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Bryant Ranch PrepackUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA078986
- TE code
- AB
- Approval date
- Nov 25, 2011
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)Dec 19, 2025
- Planned discontinuation — Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)Dec 19, 2025
- Planned discontinuation — Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)Dec 19, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Carbamazepine (Capsule, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| ANI Pharmaceuticals, Inc. | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Pharmaceuticals America, Inc. | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Validus Pharmaceuticals LLC | CARBAMAZEPINE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Validus Pharmaceuticals LLC | CARBAMAZEPINE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Validus Pharmaceuticals LLC | CARBAMAZEPINE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Carbamazepine — NDC 72162-1715-02," retrieved September 3, 2026, https://drugdashboards.com/drug/72162171502.
Free to cite with attribution — see how the data is put together.